Patents by Inventor Eric Onno
Eric Onno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11313697Abstract: Various embodiments of the present invention provide an apparatus, method, and computer program product for mapping points of interest relative to a geometric shape defined on a map. More specifically, an apparatus, method, and computer program product is provided wherein a user may view on a map a geometric shape that depicts an area within a geographic region that is expected to be reachable from a point of interest within a threshold period of time.Type: GrantFiled: April 19, 2019Date of Patent: April 26, 2022Assignee: MOVE, INC.Inventors: Jayakrishnan Vijayaraghavan, Eric Onno, Lu Zou, Milad Mohammadi, Nitin Gandhi
-
Publication number: 20200333156Abstract: Various embodiments of the present invention provide an apparatus, method, and computer program product for mapping points of interest relative to a geometric shape defined on a map. More specifically, an apparatus, method, and computer program product is provided wherein a user may view on a map a geometric shape that depicts an area within a geographic region that is expected to be reachable from a point of interest within a threshold period of time.Type: ApplicationFiled: April 19, 2019Publication date: October 22, 2020Applicant: Move, Inc.Inventors: Jayakrishnan Vijayaraghavan, Eric Onno, Lu Zou, Milad Mohammadi, Nitin Gandhi
-
Patent number: 10456458Abstract: The present invention pertains to a composition containing an immunogenic cell preparation of killed Leptospira bacteria in an ethylenediaminetetraacetic acid solution. The invention also pertains to a vaccine to protect an animal against an infection with leptospira bacteria, wherein the vaccine comprises this composition. Also, the invention pertains to the use of ethylenediaminetetraacetic acid to stabilise an immunogenic preparation of killed Leptospira bacteria in a liquid carrier, by dissolving the ethylenediaminetetraacetic acid in the carrier.Type: GrantFiled: April 16, 2018Date of Patent: October 29, 2019Assignee: Intervet Inc.Inventors: Henricus Leo Bernardus Maria Klaasen, Eric Onno Rijke
-
Publication number: 20180228900Abstract: The present invention pertains to a composition containing an immunogenic cell preparation of killed Leptospira bacteria in an ethylenediaminetetraacetic acid solution. The invention also pertains to a vaccine to protect an animal against an infection with leptospira bacteria, wherein the vaccine comprises this composition. Also, the invention pertains to the use of ethylenediaminetetraacetic acid to stabilise an immunogenic preparation of killed Leptospira bacteria in a liquid carrier, by dissolving the ethylenediaminetetraacetic acid in the carrier.Type: ApplicationFiled: April 16, 2018Publication date: August 16, 2018Applicant: Intervet Inc.Inventors: Henricus Leo Bernardus Maria Klaasen, Eric Onno Rijke
-
Patent number: 10016503Abstract: The present invention pertains to a composition containing an immunogenic cell preparation of killed Leptospira bacteria in an ethylenediaminetetraacetic acid solution. The invention also pertains to a vaccine to protect an animal against an infection with leptospira bacteria, wherein the vaccine comprises this composition. Also, the invention pertains to the use of ethylenediaminetetraacetic acid to stabilize an immunogenic preparation of killed Leptospira bacteria in a liquid carrier, by dissolving the ethylenediaminetetraacetic acid in the carrier.Type: GrantFiled: October 7, 2016Date of Patent: July 10, 2018Assignee: Intervet Inc.Inventors: Henricus Leo Bernardus Maria Klaasen, Eric Onno Rijke
-
Publication number: 20170021024Abstract: The present invention pertains to a composition containing an immunogenic cell preparation of killed Leptospira bacteria in an ethylenediaminetetraacetic acid solution. The invention also pertains to a vaccine to protect an animal against an infection with leptospira bacteria, wherein the vaccine comprises this composition. Also, the invention pertains to the use of ethylenediaminetetraacetic acid to stabilise an immunogenic preparation of killed Leptospira bacteria in a liquid carrier, by dissolving the ethylenediaminetetraacetic acid in the carrier.Type: ApplicationFiled: October 7, 2016Publication date: January 26, 2017Applicant: Intervet Inc.Inventors: Henricus Leo Bernardus Maria Klaasen, Eric Onno Rijke
-
Patent number: 9480734Abstract: The present invention pertains to a composition containing an immunogenic cell preparation of killed Leptospira bacteria in an ethylenediaminetetraacetic acid solution. The invention also pertains to a vaccine to protect an animal against an infection with leptospira bacteria, wherein the vaccine comprises this composition. Also, the invention pertains to the use of ethylenediaminetetraacetic acid to stabilize an immunogenic preparation of killed Leptospira bacteria in a liquid carrier, by dissolving the ethylenediaminetetraacetic acid in the carrier.Type: GrantFiled: August 16, 2013Date of Patent: November 1, 2016Assignee: Intervet Inc.Inventors: Henricus Leo Bernardus Maria Klaasen, Eric Onno Rijke
-
Patent number: 9375480Abstract: The present invention pertains to a composition containing an immunogenic cell preparation of killed Leptospira bacteria in a citric acid solution. It also pertains to a vaccine to protect an animal against an infection with Leptospira bacteria, wherein the vaccine comprises this composition, and to the use of citric acid to stabilize an immunogenic preparation of killed Leptospira bacteria in a liquid carrier, by dissolving the citric acid in the carrier.Type: GrantFiled: August 16, 2013Date of Patent: June 28, 2016Assignee: Intervet Inc.Inventors: Henricus Leo Bernardus Maria Klaasen, Peter Loeffen, Eric Onno Rijke
-
Publication number: 20150231223Abstract: The present invention pertains to a composition containing an immunogenic cell preparation of killed Leptospira bacteria in an ethylenediaminetetraacetic acid solution. The invention also pertains to a vaccine to protect an animal against an infection with leptospira bacteria, wherein the vaccine comprises this composition. Also, the invention pertains to the use of ethylenediaminetetraacetic acid to stabilise an immunogenic preparation of killed Leptospira bacteria in a liquid carrier, by dissolving the ethylenediaminetetraacetic acid in the carrier.Type: ApplicationFiled: August 16, 2013Publication date: August 20, 2015Inventors: Henricus Leo Bernardus Maria Klaasen, Eric Onno Rijke
-
Patent number: 6458363Abstract: The present invention is directed to a method to prepare an inactivated w/o emulsion adjuvated vaccine, wherein an aqueous solution comprising one or more inactivated angigens is mixed under mild conditions with a ready-made w/o emulsion. Preferably the vaccine is prepared just prior to vaccination. The aqueous solution and w/o emulsion are stirred or shaken by mechanical means or by hand. The present invention also relates to a kit of parts for use in a method according to the invention.Type: GrantFiled: June 21, 2001Date of Patent: October 1, 2002Assignee: Akzo Nobel N.V.Inventors: Carla Christina Schrier, Eric Onno Rijke
-
Patent number: 5667784Abstract: Oil based vaccines often cause serious local side effects at the site of administration and/or have a high viscosity which make said vaccines difficult to handle. Vaccines comprising as an adjuvant a stable emulsion of tocols in water do not display these undesired effects and induce good immune responses.Type: GrantFiled: June 5, 1995Date of Patent: September 16, 1997Assignee: Akzo Nobel, N.V.Inventors: Lammert Cornelius, Eric Onno Rijke
-
Patent number: 5650155Abstract: Oil based vaccines often cause serious local side effects at the site of administration and/or have a high viscosity which make said vaccines difficult to handle. Vaccines comprising as an adjuvant a stable emulsion of tocols in water do not display these undesired effects and induce good immune responses.Type: GrantFiled: October 7, 1994Date of Patent: July 22, 1997Assignee: AKZO Nobel N.V.Inventors: Lammert Cornelius, Eric Onno Rijke